Pages that link to "Q45049913"

The following pages link to Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro (Q45049913):

Displaying 49 items.

• Glutamatergic substrates of drug addiction and alcoholism (Q24648924) (← links)
• New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels (Q24654230) (← links)
• Molecular targets for antiepileptic drug development (Q24683346) (← links)
• Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia (Q26764876) (← links)
• Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels (Q30498941) (← links)
• Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus (Q33569536) (← links)
• Resolution of pregabalin and mirtazapine associated restless legs syndrome by bupropion in a patient with major depressive disorder (Q33600358) (← links)
• Amphetamine toxicities: classical and emerging mechanisms. (Q34102002) (← links)
• Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: Basic characterization and drug pharmacology (Q34191697) (← links)
• Pregabalin in acute and chronic pain (Q34214071) (← links)
• A comparative study of pre-operative oral clonidine and pregabalin on post-operative analgesia after spinal anesthesia (Q34237071) (← links)
• An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy (Q34590272) (← links)
• New Horizons in the development of antiepileptic drugs: Innovative strategies (Q35046545) (← links)
• Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2+ α2δ-1 subunit (Q35077880) (← links)
• Gabapentin inhibits catecholamine release from adrenal chromaffin cells (Q35925069) (← links)
• Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision (Q36231851) (← links)
• Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets (Q36576250) (← links)
• Pregabalin for pain management (Q36687433) (← links)
• Cellular and behavioral interactions of gabapentin with alcohol dependence (Q36805266) (← links)
• Gabapentin potentiates sensitivity to the interoceptive effects of alcohol and increases alcohol self-administration in rats (Q36872261) (← links)
• Neuroprotective Effects of Pregabalin on Cerebral Ischemia and Reperfusion (Q37047190) (← links)
• Efficacy and tolerability of pregabalin in partial epilepsy. (Q37203346) (← links)
• Gabapentin alleviates facet-mediated pain in the rat through reduced neuronal hyperexcitability and astrocytic activation in the spinal cord (Q37360632) (← links)
• Review about gabapentin misuse, interactions, contraindications and side effects (Q37641479) (← links)
• In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures. (Q37682393) (← links)
• Glutamatergic medications for the treatment of drug and behavioral addictions (Q37871133) (← links)
• P/Q-type calcium channel modulators (Q38016449) (← links)
• Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety (Q38025453) (← links)
• Effects of pregabalin on sleep in generalized anxiety disorder (Q38046292) (← links)
• Pregabalin for alcohol dependence: a critical review of the literature (Q38058284) (← links)
• Emerging drugs for focal epilepsy. (Q38062011) (← links)
• Recent patents on calcium channel blockers: emphasis on CNS diseases. (Q38239508) (← links)
• Gabapentin in Headache Disorders: What Is the Evidence? (Q38591703) (← links)
• Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurones of the rat entorhinal cortex in vitro. (Q40793129) (← links)
• Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex (Q41190061) (← links)
• Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate (Q41360645) (← links)
• Disturbance of consciousness and involuntary movements caused by pregabalin (Q42265954) (← links)
• Gabapentin decreases epileptiform discharges in a chronic model of neocortical trauma (Q42553592) (← links)
• Pharmacotherapy of alcoholism - an update on approved and off-label medications (Q43061723) (← links)
• Pregabalin abuse and dependence in Germany: results from a database query (Q44066305) (← links)
• Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes (Q46252236) (← links)
• Gabapentin for the treatment of alcohol use disorder. (Q47309377) (← links)
• Gabapentin Prevents Progressive Increases in Excitatory Connectivity and Epileptogenesis Following Neocortical Trauma (Q48032757) (← links)
• Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat. (Q48151987) (← links)
• Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial (Q48198524) (← links)
• Pregabalin is effective against behavioral and electrographic seizures during alcohol withdrawal (Q48569673) (← links)
• Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat. (Q51855387) (← links)
• Upregulation of cortical GABAA receptor concentration in fibromyalgia (Q90379837) (← links)
• Efficacy of a Combination of N-Palmitoylethanolamide, Beta-Caryophyllene, Carnosic Acid, and Myrrh Extract on Chronic Neuropathic Pain: A Preclinical Study (Q91970792) (← links)